Ibrance (Palbociclib) and Verzenio (Abemaciclib) are both kinase inhibitors used to treat metastatic breast cancer. Here are some details about each:
Ibrance (Palbociclib)
- Usage: Taken once daily in capsule form
- Common Side Effects: Low blood cell counts, infections, fatigue, nausea, stomach flu, hair loss, diarrhea, Show Full Answer
Ibrance (Palbociclib) and Verzenio (Abemaciclib) are both kinase inhibitors used to treat metastatic breast cancer. Here are some details about each:
Ibrance (Palbociclib)
- Usage: Taken once daily in capsule form.
- Common Side Effects: Low blood cell counts, infections, fatigue, nausea, stomach flu, hair loss, diarrhea, rash, vomiting, decreased appetite, weakness, and fever.
- Serious Side Effects: Severe infections and pulmonary embolisms (blood clots in the lungs).
Verzenio (Abemaciclib)
- Usage: Taken twice daily with meals in tablet form.
- Common Side Effects: Headache, fatigue, infections, blood cell changes, nausea, vomiting, loss of appetite, diarrhea, and abdominal pain.
- Serious Side Effects: Severe diarrhea, lung disease, liver damage, and venous thromboembolisms (blood clots in the veins). It can also harm the fetus if taken by pregnant women.
Comparison to Chemotherapy
- Chemotherapy: Often associated with more severe side effects like extensive hair loss, severe nausea, and a higher risk of infections due to more significant immune suppression.
Personal Experiences
- Ibrance: 401 women have indicated they have taken Ibrance.
- Verzenio: 48 women have indicated they have taken Verzenio.
For more personalized experiences, you might consider joining a community like MyBCTeam, where members share their experiences and support each other.
September 25, 2024
Join
Your Privacy Choices
